Answers are grounded in this paper and cite their sources.
Introduction: Immunosuppressive drug use is common in the treatment of systemic lupus erythematosus (SLE). In cases receiving immunosuppressive therapy, screening for hepatitis B reactivation risk is also recommended. In this study, we aimed to investigate the frequency of hepatitis B screening in cases diagnosed as having SLE, who were followed up in the Rheumatology Clinic of Hatay Mustafa Kemal University.
No takes yet. Share an insight, caveat, or question.
Çabalak et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: